Keratoconjunctivitis sicca associated with administration of etodolac in dogs: 211 cases (1992-2002)

Journal of the American Veterinary Medical Association

Volumn 230, Issue 4, 2007, Pages 541-547

  Klauss, Gia ^a,d   Giuliano, Elizabeth A ^a   Moore, Cecil P ^a   Stuhr, Charles M ^b   Martin, Stacy L ^c   Tyler, Jeff W ^a   Fitzgerald, Kelsie E ^b   Crawford, Debra A ^c  

^a UNIVERSITY OF MISSOURI   (United States)

^b Animal Eye Clinic   (United States)

^c ZOETIS   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETODOLAC; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; DRUG EFFECT; FEMALE; HOSPITALIZATION; KERATOCONJUNCTIVITIS SICCA; LACRIMAL FLUID; MALE; ORAL DRUG ADMINISTRATION; PATHOLOGY; RETROSPECTIVE STUDY; SECRETION; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOG DISEASES; DOGS; ETODOLAC; FEMALE; KERATOCONJUNCTIVITIS SICCA; LOGISTIC MODELS; MALE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TEARS; TIME FACTORS; TREATMENT OUTCOME;

ANIMALIA; CANIS FAMILIARIS;

EID: 33847794086     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.230.4.541     Document Type: Article

References (50)

1. Moore CP. Diseases and surgery of the lacrimal secretory system. In: Gelatt KN, ed. Veterinary ophthalmology. 3rd ed. Philadelphia: Lea & Febiger, 1999;583-607.
2. Sansom J, Barnett KC. Keratoconjunctivitis sicca in the dog: a review of two hundred cases. J Small Anim Pract 1985;26:121-131.
3. Kaswan RL, Salisbury MA. A new perspective on canine keratoconjunctivitis sicca. Treatment with ophthalmic cyclosporine. Vet Clin North Am Small Anim Pract 1990;20:583-613.
4. Helper LC. The tear film in the dog. Anim Eye Res 1996;15:5-11.
5. Brown MH, Galland JC, Davidson HJ, et al. The phenol red thread tear test in dogs. Vet Comp Ophthalmol 1996;6:274-277.
6. Gelatt KN. Vital staining of the canine cornea and conjunctiva with rose Bengal. J Am Anim Hasp Assoc 1972;8:17-22.
7. Gelatt KN, Peiffer RL Jr, Erickson JL, et al. Evaluation of tear function in the dog using a modification of the Schirmer tear test. J Am Vet Med Assoc 1975;166:368-370.
8. Hawkins EC, Murphy CJ. Inconsistencies in the absorptive capacities of Schirmer tear test strips. J Am Vet Med Assoc 1986;188:511-513.
9. Wyman M, Gilger BC, Mueller P, et al. Clinical evaluation of a new Schirmer tear test in the dog. Vet Comp Ophthalmol 1995;5:211-214.
10. Aguirre GD, Rubin LF, Harvey CE. Keratoconjunctivitis sicca in dogs. J Am Vet Med Assoc 1971;158:1566-1579.
11. Kaswan RL, Martin CL, Dawe DL. Keratoconjunctivitis sicca: immunological evaluation of 62 canine cases. Am J Vet Res 1985;46:376-383.
12. Kaswan RL, Martin CL, Chapman WL Jr. Keratoconjunctivitis sicca: histopathologic study of nictitating membrane and lacrimal glands from 28 dogs. Am J Vet Res 1984;45:112-118.
13. Peruccio C. Incidence of hypothyroidism in dogs affected by keratoconjunctivitis sicca. Trans Am Coll Vet Ophthalmol 1982:47-48.
14. Barrera R, Cinta Mane M, Rodriguez JF, et al. Keratoconjunctivitis sicca and diabetes mellitus in a dog. J Am Vet Med Assoc 1992;200:1967-1968.
15. Kaswan R, Pappas C Jr, Wall K, et al. Survey of canine tear deficiency in veterinary practice. Adv Exp Med Biol 1998;438:931-939.
16. Wise LA, Lappin MR. A syndrome resembling feline dysautonomia (Key-Gaskell syndrome) in a dog. J Am Vet Med Assoc 1991;198:2103-2106.
17. Kern TJ, Erb HN. Facial neuropathy in dogs and cats: 95 cases (1975-1985). J Am Vet Med Assoc 1987;191:1604-1609.
18. Martin CL. Distemper-associated keratoconjunctivitis sicca. J Am Hasp Assoc 1985;21:355-359.
19. Pena MT, Roura X, Davidson MG. Ocular and periocular manifestations of leishmaniasis in dogs: 105 cases. Vet Ophthalmol 2000;3:35-41.
20. Roberts SM, Lavach JD, Severin GA, et al. Ophthalmic complications following megavoltage irradiation of the nasal and paranasal cavities in dogs. J Am Vet Med Assoc 1987;190:43-47.
21. Helper LC. The effect of lacrimal gland removal on the conjunctiva and cornea of the dog. J Am Vet Med Assoc 1970;157:72-75.
22. Helper LC, Magrane WG, Koehm J, et al. Surgical induction of keratoconjunctivitis sicca in the dog. J Am Vet Med Assoc 1974;165:172-174.
23. Herring IP, Pickett JP, Champagne ES, et al. Evaluation of aqueous tear production in dogs following general anesthesia. J Am Anim Hasp Assoc 2000;36:427-430.
24. Hollingsworth SR, Canton DD, Buyukmihci NC, et al. Effect of topically administered atropine on tear production in dogs. J Am Vet Med Assoc 1992;200:1481-1484.
25. Sansom J, Barnett KC, Long RD. Keratoconjunctivitis sicca in the dog associated with the administration of salicylazosulphapyridine (sulphasalazine). Vet Record 1985;116:391-393.
26. Aguirre GD. Keratoconjunctivitis sicca caused by sulfadiazine. J Am Vet Med Assoc 1973;162:8.
27. Slatter DH, Blogg JR. Keratoconjunctivitis sicca in dogs associated with sulphonamide administration. Aust Vet J 1978;54:444-446.
28. Morgan RY Bachrach A Jr. Keratoconjunctivitis sicca associated with sulfonamide therapy in dogs. J Am Vet Med Assoc 1982;180:432-434.
29. Diehl KJ, Roberts SM. Keratoconjunctivitis sicca in dogs associated with sulfonamide therapy: 16 cases (1980-1990). Prog Vet Comp Ophthalmol 1991;l:276-282.
30. Todenhoefer H. Nebenwirkungen von Sulfadiazin ber der Anwendung als Geriatrikum fuer Hunde. Dtsch Tieraerztl Wochenschr 1969;76:14-16.
31. Bilyard KG, Joseph EC, Metcalf R. Mesalazine: an overview of key preclinical studies. Scand J Gastroenterol Suppl 1990;172:52-55.
32. Barnett KC, Joseph EC. Keratoconjunctivitis sicca in the dog following 5-aminosalicylic acid administration. Hum Toxicol 1987;6:377-383.
33. Houston DM, Keller CB. Keratoconjunctivitis sicca in the dog following prolonged use of salazopyrin and other 5-ASA containing drugs for treatment of canine colitis. Can Vet J 1989;30:437.
34. Bryan GM, Slatter DH. Keratoconjunctivitis sicca induced by phenazopyridine in dogs. Arch Ophthalmol 1973;90:310-311.
35. Slatter DH. Keratoconjunctivitis sicca in the dog produced by oral phenazopyridine hydrochloride. J Small Anim Pract 1973; 14:749-771.
36. Slatter DH, Davis WC. Toxicity of phenazopyridine. Electron microscopical studies of canine lacrimal and nictitans glands. Arch Ophthalmol 1974;91:484-486.
37. Avisar R, Deutsch D, Savir H. Keratoconjunctivitis sicca induced by dipyrone. Harefuah 1988;114:543-545.
38. Stiles J. Warning of an adverse effect of etodolac (lett). J Am Vet Med Assoc 2004;225:503.
39. EtoGesic [package insert]. Fort Dodge, Iowa: Fort Dodge Animal Health, 2000.
40. Berger SL, Scagliotti RH, Lund EM. A quantitative study of the effects of Tribrissen on canine tear production. J Am Anim Hosp Assoc 1995;31:236-241.
41. Cayen MN, Kraml M, Ferdinandi ES, et al. The metabolic disposition of etodolac in rats, dogs, and man. Drug Metab Rev 1981;12:339-362.
42. Wrenn JM, Inhelder JL, Hemm RD, et al. One year chronic toxicity study of etodolac, a nonsteroidal anti-inflammatory agent, in the Beagle dog. Oyo Yakuri 1990;40:599-646.
43. Mabee CL, Mabee SW, Baker PB, et al. Fulminant hepatic failure associated with etodolac use. Am J Gastroenterol 1995;90: 659-661.
44. Cramer RL, Aboko-Cole VC, Gualtieri RJ. Agranulocytosis associated with etodolac. Ann Pharmacother 1994;28:458-460.
45. Cunha PD, Lord RS, Johnson ST, et al. Immune hemolytic anemia caused by sensitivity to a metabolite of etodolac, a nonsteroidal anti-inflammatory drug. Transfusion 2000;40:663-668.
46. Trepanier LA. Delayed hypersensitivity reactions to sulphonamides: syndromes, pathogenesis and management. Vet Dermatol 1999;10:241-248.
47. Kaswan RL, Salisbury MA, Lothrop CD Jr. Interaction of age and gender on occurrence of canine keratoconjunctivitis sicca. Prog Vet Comp Ophthalmol 1991;1:93-97.
48. Barnett KC. Keratoconjunctivitis sicca: sex incidence. J Small Anim Pract 1988;29:531-534.
49. Bouw J. Hip dysplasia and dog breeding. Vet Q 1982;4:173-181.
50. Smith GK, Mayhew PD, Kapatkin AS, et al. Evaluation of risk factors for degenerative joint disease associated with hip dysplasia in German Shepherd Dogs, Golden Retrievers, Labrador Retrievers, and Rottweilers. J Am Vet Med Assoc 2001;219:1719-1724.